SIRT2 expression is reported to be both upregulated and downregulated under hyperglycemia, with its knockdown enhancing cell proliferation and reducing apoptosis, suggesting a potential role in DKD pathology; meanwhile, SIRT6 is linked to increased TNF-α expression, suggesting a role in inflammation [22,88,89]. Here, SIRT6 is linked to diabetic kidney disease.